AMLX
#1564
Amylyx Pharmaceuticals, Inc. - Common Stock
33.7 5 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-2.85%
Changement Mensuel
+66.34%
Evolution sur 6 mois
+125.00%
Changement Annuel
+266.85%
Clôture Précédente
34.7 4
Open
33.7 5
Low
33.7 5
High
33.7 5
Volume
174
Financials
- Market Capitalization 3.76 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-12.74
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1547 |  VKTX Viking Therapeutics, Inc. - Common Stock | 32.78 USD | +1.93% | -2.64% | +3.11% | +21.54% | 3.82 B USD | ||
| 1552 |  TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.09 USD | -1.77% | -4.97% | +8.73% | +75.75% | 3.76 B USD | ||
| 1568 |  RCUS Arcus Biosciences, Inc. Common Stock | 29.26 USD | +0.24% | -5.09% | +4.95% | +177.08% | 3.73 B USD | ||
| 1580 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 8.17 USD | +2.00% | +0.12% | +99.27% | +273.06% | 3.70 B USD |